Bioactivity of vitamin E

Nutrition Research Reviews

Volumn 19, Issue 2, 2006, Pages 174-186

  Brigelius Flohé, Regina ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

tocopherol; Antioxidants; Bioactivity; Vitamers; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; BETA TOCOPHEROL; DELTA TOCOPHEROL; GAMMA TOCOPHEROL;

ALPHA TOCOPHEROL DEFICIENCY; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COLON CANCER; DRUG ACTIVITY; DRUG METABOLISM; DRUG STRUCTURE; GENE EXPRESSION; HUMAN; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; NERVE DEGENERATION; NONHUMAN; PROSTATE CANCER; REVIEW; VITAMIN SUPPLEMENTATION;

MAMMALIA;

EID: 33846807312     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422407202938     Document Type: Review

References (136)

1. Abe C, Ikeda S & Yamashita K (2005) Dietary sesame seeds elevate α-tocopherol concentration in rat brain. Journal of Nutritional Science and Vitaminology (Tokyo) 51, 223-230.
2. Aranda A & Pascual A (2001) Nuclear hormone receptors and gene expression. Physiological Reviews 81, 1269-1304.
3. Aratri E, Spycher SE, Breyer I & Azzi A (1999) Modulation of α-tropomyosin expression by α-tocopherol in rat vascular smooth muscle cells. FEBS Letters 447, 91-94.
4. Azzi A & Stocker A (2000) Vitamin E: non-antioxidant roles. Progress in Lipid Research 39, 231-255.
5. Azzi A, Gysin R, Kempna P, Munteanu A, Villacorta L, Visarius T & Zingg JM (2004) Regulation of gene expression by α-tocopherol. Biological Chemistry 385, 585-591.
6. Barella L, Muller PY, Schlachter M, Hunziker W, Stöcklin E, Spitzer V, Meier N, de Pascual-Teresa S, Minihane AM & Rimbach G (2004) Identification of hepatic molecular mechanisms of action of α-tocopherol using global gene expression profile analysis in rats. Biochimica et Biophysica Acta 1689, 66-74.
7. Ben Hamida M, Belal S, Sirugo G, et al. (1993) Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred. Neurology 43, 2179-2183.
8. Berman K & Brodaty H (2004) Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders. CNS Drugs 18, 807-825.
9. Betancor-Fernandez A, Sies H, Stahl W & Polidori MC (2002) 2,5,7,8-Tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (α-CEHC), a vitamin E metabolite in human serum and urine, possesses antioxidant activity. Free Radical Research 36, 915-921.
10. Birringer M, Drogan D & Brigelius-Flohé R (2001) Tocopherols are metabolized in HepG2 cells by side chain ω-oxidation and consecutive β-oxidation. Free Radical Biology and Medicine 31, 226-232.
11. Boscoboinik D, Szewczyk A & Azzi A (1991) α-Tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Archives of Biochemistry and Biophysics 286, 264-269.
12. Brigelius-Flohé R (2003) Vitamin E and drug metabolism. Biochemical and Biophysical Research Communications 305, 737-740.
13. Brigelius-Flohé R (2005) Induction of drug metabolizing enzymes by vitamin E. Journal of Plant Physiology 162, 797-802.
14. Brigelius-Flohé R, Kelly FJ, Salonen J, Neuzil J, Zingg J-M & Azzi A (2002a) The European perspective on vitamin E: current knowledge and future research. American Journal of Clinical Nutrition 76, 703-716.
15. Brigelius-Flohé R, Kluth D, Landes N, Pfluger P & Birringer M (2002b) Mechanisms of vitamin E metabolism. In The Antioxidant Vitamins C and E, pp. 171-179 [L Packer, M Traber, K Kraemer and B Frei, editors]. Champaign, IL: AOCS Press.
16. Brigelius-Flohé R & Traber MG (1999) Vitamin E: function and metabolism. FASEB Journal 13, 1145-1155.
17. Burton GW & Ingold KU (1981) Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chainbreaking phenolic antioxidants in vitro. Journal of the American Chemical Society 103, 6472-6477.
18. Burton GW, Joyce A & Ingold KU (1982) First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma. Lancet ii, 327.
19. Burton GW & Traber MG (1990) Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annual Review of Nutrition 10, 357-382.
20. Cachia O, Benna JE, Pedruzzi E, Descomps B, Gougerot-Pocidalo MA & Leger CL (1998) α-Tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. Journal of Biological Chemistry 273, 32801-32805.
21. Campbell S, Stone W, Whaley S & Krishnan K (2003a) Development of gamma (γ)-tocopherol as a colorectal cancer chemopreventive agent. Critical Reviews in Oncology/Hematology 47, 249-259.
22. Campbell SE, Stone WL, Whaley SG, Qui M & Krishnan K (2003b) Gamma (γ) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (γ) expression in SW 480 human colon cancer cell lines. BMC Cancer 3, 25.
23. Chatelain E, Boscoboinik DO, Bartoli GM, Kagan VE, Gey FK, Packer L & Azzi A (1993) Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochimica et Biophysica Acta 1176, 83-89.
24. Chiku S, Hamamura K & Nakamura T (1984) Novel urinary metabolite of d-δ-tocopherol in rats. Journal of Lipid Research 25, 40-48.
25. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW & Ames BN (1997) γ-Tocopherol traps mutagenic electrophiles such as NO(X) and complements α-tocopherol: physiological implications. Proceedings of the National Academy of Sciences USA 94, 3217-3222.
26. Cooney RV, Custer LJ, Okinaka L & Franke AA (2001) Effects of dietary sesame seeds on plasma tocopherol levels. Nutrition and Cancer 39, 66-71.
27. Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ & Mordan LJ (1993) γ-Tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proceedings of the National Academy of Sciences USA 90, 1771-1775.
28. De Pascale MC, Bassi AM, Patrone V, Villacorta L, Azzi A & Zingg JM (2006) Increased expression of transglutaminase-1 and PPARγ after vitamin E treatment in human keratinocytes. Archives of Biochemistry and Biophysics 447, 97-106.
29. Fischer A, Pallauf J, Gohil K, Weber SU, Packer L & Rimbach G (2001) Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochemical and Biophysical Research Communications 285, 470-475.
30. Frank J, Kamal-Eldin A, Lundh T, Maatta K, Torronen R & Vessby B (2002) Effects of dietary anthocyanins on tocopherols and lipids in rats. Journal of Agricultural and Food Chemistry 50, 7226-7230.
31. Frank J, Kamal-Eldin A, Razdan A, Lundh T & Vessby B (2003a) The dietary hydroxycinnamate caffeic acid and its conjugate chlorogenic acid increase vitamin E and cholesterol concentrations in Sprague-Dawley rats. Journal of Agricultural and Food Chemistry 51, 2526-2531.
32. Frank J, Lundh T, Parker RS, Swanson JE, Vessby B & Kamal-Eldin A (2003b) Dietary (+)-catechin and BHT markedly increase α-tocopherol concentrations in rats by α-tocopherol-ω-hydroxylase-independent mechanism. Journal of Nutrition 133, 3195-3199.
33. Galli F, Lee R, Atkinson J, Floridi A & Kelly FJ (2003) γ-Tocopherol biokinetics and transformation in humans. Free Radical Research 37, 1225-1233.
34. Galli F, Lee R, Dunster C & Kelly FJ (2002) Gas chromatography mass spectrometry analysis of carboxyethyl-hydroxychroman metabolites of α- and γ-tocopherol in human plasma. Free Radical Biology and Medicine 32, 333-340.
35. Galli F, Stabile AM, Betti M, Conte C, Pistilli A, Rende M, Floridi A & Azzi A (2004) The effect of α- and γ-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Archives of Biochemistry and Biophysics 423, 97-102.
36. Genkinger JM, Platz EA, Hoffman SC, Comstock GW & Helzlsouer KJ (2004) Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. American Journal of Epidemiology 160, 1223-1233.
37. Gimeno A, Zaragoza R, Vina JR & Miralles VJ (2004) Vitamin E activates CRABP-II gene expression in cultured human fibroblasts, role of protein kinase C. FEBS Letters 569, 240-244.
38. Gohil K, Godzdanker R, O'Roark E, Schock BC, Kaini RR, Packer L, Cross CE & Traber MG (2004) α-Tocopherol transfer protein deficiency in mice causes multi-organ deregulation of gene networks and behavioral deficits with age. Annals of the New York Academy of Sciences 1031, 109-126.
39. Gohil K, Schock BC, Chakraborty AA, Terasawa Y, Raber J, Farese RV Jr, Packer L, Cross CE & Traber MG (2003) Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in α-tocopherol transfer protein. Free Radical Biology and Medicine 35, 1343-1354.
40. Gysin R, Azzi A & Visarius T (2002) γ-Tocopherol inhibits human cancer cell cycle progression and cell proliferation by downregulation of cyclins. FASEB Journal 16, 1952-1954.
41. Hattori A, Fukushima T, Yoshimura H, Abe K & Ima K (2000) Production of LLU-α following an oral administration of γ-tocotrienol or γ-tocopherol to rats. Biological and Pharmaceutical Bulletin 23, 1395-1397.
42. Hayton SM, Kriss T, Wade A & Muller DP (2006) Effects on neural function of repleting vitamin E-deficient rats with α-tocopherol. Journal of Neurophysiology 95, 2553-2559.
43. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23-33.
44. Heinonen OP, Albanes D, Virtamo J, et al. (1998) Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. Journal of the National Cancer Institute 90, 440-446.
45. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS & Comstock GW (2000) Association between α-tocopherol, γ-tocopherol, selenium, and subsequent prostate cancer. Journal of the National Cancer Institute 92, 2018-2023.
46. Hensley K, Benaksas EJ, Bolli R, et al. (2004) New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine. Free Radical Biology and Medicine 36, 1-15.
47. Hentati A, Deng HX, Hung WY, Nayer M, Ahmed MS, He X, Tim R, Stumpf DA & Siddique T (1996) Human α-tocopherol transfer protein: gene structure and mutations in familial vitamin E deficiency. Annals of Neurology 39, 295-300.
48. Hoglen NC, Waller SC, Sipes IG & Liebler DC (1997) Reactions of peroxynitrite with γ-tocopherol. Chemical Research in Toxicology 10, 401-407.
49. Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H & Inoue K (1997) Affinity of α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Letters 409, 105-108.
50. Hsieh CC, Huang CJ & Lin BF (2006) Low and high levels of α-tocopherol exert opposite effects on IL-2 possibly through the modulation of PPAR-γ, IκBα, and apoptotic pathway in activated splenocytes. Nutrition 22, 433-440.
51. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW & Helzlsouer KJ (2003) Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. American Journal of Epidemiology 157, 335-344.
52. Ikeda S, Tohyama T & Yamashita K (2002) Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl-2(2′-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed γ-tocopherol. Journal of Nutrition 132, 961-966.
53. Ikeda S, Tohyama T, Yoshimura H, Hamamura K, Abe K & Yamashita K (2003) Dietary α-tocopherol decreases α-tocotrienol but not γ-tocotrienol concentration in rats. Journal of Nutrition 133, 428-434.
54. Jervis KM & Robaire B (2004) The effects of long-term vitamin E treatment on gene expression and oxidative stress damage in the aging Brown Norway rat epididymis. Biology of Reproduction 71, 1088-1095.
55. Jiang Q & Ames BN (2003) γ-Tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB Journal 17, 816-822.
56. Jiang Q, Christen S, Shigenaga MK & Ames BN (2001) γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. American Journal of Clinical Nutrition 74, 714-722.
57. Jiang Q, Elson-Schwab I, Courtemanche C & Ames BN (2000) γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proceedings of the National Academy of Sciences USA 97, 11494-11499.
58. Jiang Q, Wong J & Ames BN (2004) γ-Tocopherol induces apoptosis in androgen-responsive LNCaP prostate cancer cells via caspase-dependent and independent mechanisms. Annals of the New York Academy of Sciences 1031, 399-400.
59. Jishage K, Arita M, Igarashi K, Iwata T, Watanabe M, Ogawa M, Ueda O, Kamada N, Inoue K, Arai H & Suzuki H (2001) α-Tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. Journal of Biological Chemistry 276, 1669-1672.
60. Kamal-Eldin A & Appelqvist LA (1996) The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 31, 671-701.
61. Kamal-Eldin A, Frank J, Razdan A, Tengblad S, Basu S & Vessby B (2000) Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids 35, 427-435.
62. Kerckhoffs D, Brouns F, Hornstra G & Mensink RP (2002) Effects on the human serum lipoprotein profile of β-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. Journal of Nutrition 132, 2494-2505.
63. Kiyose C, Saito H, Kaneko K, Hamamura K, Tomioka M, Ueda T & Igarashi O (2001) α-Tocopherol affects the urinary and biliary excretion of 2,7,8- trimethyl-2 (2′-carboxyethyl)-6-hydroxychroman, γ-tocopherol metabolite, in rats. Lipids 36, 467-472.
64. Kluth D, Landes N, Pfluger P, Müller-Schmehl K, Weiss K, Bumke-Vogt C, Ristow M & Brigelius-Flohé R (2005) Modulation of Cyp3a11 mRNA expression by α-tocopherol but not γ-tocotrienol in mice. Free Radical Biology and Medicine 38, 507-514.
65. Landes N, Pfluger P, Kluth D, Birringer M, Rühl R, Böl GF, Glatt H & Brigelius-Flohé R (2003) Vitamin E activates gene expression via the pregnane X receptor. Biochemical Pharmacology 65, 269-273.
66. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT & Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Journal of Clinical Investigation 102, 1016-1023.
67. Leist M, Raab B, Maurer S, Rosick U & Brigelius-Flohé R (1996) Conventional cell culture media do not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicity. Free Radical Biology and Medicine 21, 297-306.
68. Lemcke-Norojäryi M, Kamal-Eldin A, Appelqvist LA, Dimberg LH, Öhrvall M & Vessby B (2001) Corn and sesame oils increase serum γ-tocopherol concentrations in healthy Swedish women. Journal of Nutrition 131, 1195-1201.
69. Leonard SW, Gumpricht E, Devereaux MW, Sokol RJ & Traber MG (2005a) Quantitation of rat liver vitamin E metabolites by LC-MS during high-dose vitamin E administration. Journal of Lipid Research 46, 1068-1075.
70. Leonard SW, Paterson E, Atkinson JK, Ramakrishnan R, Cross CE & Traber MG (2005b) Studies in humans using deuterium-labeled α- and γ-tocopherols demonstrate faster plasma γ-tocopherol disappearance and greater γ-metabolite production. Free Radical Biology and Medicine 38, 857-866.
71. Lodge JK, Ridlington J, Leonard S, Vaule H & Traber MG (2001) α- and γ-Tocotrienols are metabolized to carboxyethylhydroxychroman derivatives and excreted in human urine. Lipids 36, 43-48.
72. Lonn E, Bosch J, Yusuf S, et al. (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. Journal of the American Medical Association 293, 1338-1347.
73. McCormick CC & Parker RS (2004) The cytotoxicity of vitamin E is both vitamer- and cell-specific and involves a selectable trait. Journal of Nutrition 134, 3335-3342.
74. McIntyre BS, Briski KP, Gapor A & Sylvester PW (2000a) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proceedings of the Society for Experimental Biology and Medicine 224, 292-301.
75. McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A & Sylvester PW (2000b) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35, 171-180.
76. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ & Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Annals of Internal Medicine 142, 37-46.
77. Mo HB & Elson CE (2004) Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Experimental Biology and Medicine 229, 567-585.
78. Munteanu A, Taddei M, Tamburini I, Bergamini E, Azzi A & Zingg JM (2006) Antagonistic effects of oxidized low density lipoprotein and α-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-γ. Journal of Biological Chemistry 281, 6489-6497.
79. Munteanu A, Zingg JM & Azzi A (2004) Anti-atherosclerotic effects of vitamin E - myth or reality? Journal of Cellular and Molecular Medicine 8, 59-76.
80. Murray ED, Wechter WJ, Kantoci D, Wang WH, Pham T, Quiggle DD, Gibson KM, Leipold D & Anner BM (1997) Endogenous natriuretic factors. 7. Biospecificity of a natriuretic γ-tocopherol metabolite LLU-α. Journal of Pharmacology and Experimental Therapeutics 282, 657-662.
81. Mustad VA, Smith CA, Ruey PP, Edens NK & DeMichele SJ (2002) Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. American Journal of Clinical Nutrition 76, 1237-1243.
82. Nesaretnam K, Khor HT, Ganeson J, Chong YH, Sundram K & Gapor A (1992) The effect of vitamin-E tocotrienols from palm oil on chemically-induced mammary carcinogenesis in female rats. Nutrition Research 12, 879-892.
83. Nesaretnam K, Stephen R, Dils R & Darbre P (1998) Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33, 461-469.
84. O'Byrne D, Grundy S, Packer L, Devaraj S, Baldenius K, Hoppe PP, Kraemer K, Jialal I & Traber MG (2000) Studies of LDL oxidation following α-, γ-, or δ-tocotrienyl acetate supplementation of hypercholesterolemic humans. Free Radical Biology and Medicine 29, 834-845.
85. Ouahchi K, Arita M, Kayden H, Hentati F, Hamida MB, Sokol R, Arai H, Inoue K, Mandel J-L & Koenig M (1995) Ataxia with isolated vitamin E deficiency is caused by mutations in the α-tocopherol transfer protein. Nature Genetics 9, 141-145.
86. Parker RS, Sontag TJ & Swanson JE (2000) Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochemical and Biophysical Research Communications 277, 531-534.
87. Parker RS & Swanson JE (2000) A novel 5′-carboxychroman metabolite of γ-tocopherol secreted by HepG2 cells and excreted in human urine. Biochemical and Biophysical Research Communications 269, 580-583.
88. Petersen RC, Thomas RG, Grundman M, et al. (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine 352, 2379-2388.
89. Pfluger P, Kluth D, Landes N, Bumke-Vogt C & Brigelius-Flohé R (2004) Vitamin E: underestimated as an antioxidant. Redox Report 9, 249-254.
90. Pham DQ & Plakogiannis R (2005) Vitamin E supplementation in cardiovascular disease and cancer prevention: part 1. Annals of pharmacotherapy 39, 1870-1878.
91. Podda M, Weber C, Traber MG & Packer L (1996) Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. Journal of Lipid Research 37, 893-901.
92. Poston L, Briley AL, Seed PT, Kelly FJ & Shennan AH (2006) Vitamin C and vitamin E in pregnant women at risk for preeclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367, 1145-1154.
93. Qureshi AA, Sami SA, Salser WA & Khan FA (2002) Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 161, 199-207.
94. Radosavac D, Graf P, Polidori MC, Sies H & Stahl W (2002) Tocopherol metabolites 2, 5, 7, 8-tetramethyl-2-(2′-carboxyethyl)-6- hydroxychroman (α-CEHC) and 2, 7, 8-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman (γ-CEHC) in human serum after a single dose of natural vitamin E. European Journal of Nutrition 41, 119-124.
95. Ricciarelli R, Tasinato A, Clement S, Özer NK, Boscoboinik D & Azzi A (1998) α-Tocopherol specifically inactivates cellular protein kinase C α by changing its phosphorylation state. Biochemical Journal 334, 243-249.
96. Ricciarelli R, Zingg JM & Azzi A (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 102, 82-87.
97. Rota C, Barella L, Minihane AM, Stocklin E & Rimbach G (2004) Dietary α-tocopherol affects differential gene expression in rat testes. IUBMB Life 56, 277-280.
98. Roy S, Lado BH, Khanna S & Sen CK (2002) Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Letters 530, 17-23.
99. Saito H, Kiyose C, Yoshimura H, Ueda T, Kondo K & Igarashi O (2003) γ-Tocotrienol, a vitamin E homolog, is a natriuretic hormone precursor. Journal of Lipid Research 44, 1530-1535.
100. Sano M, Ernesto C, Thomas RG, et al. (1997) A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. New England Journal of Medicine 336, 1216-1222.
101. Schaffer S, Müller WE & Eckert GP (2005) Tocotrienols: constitutional effects in aging and disease. Journal of Nutrition 135, 151-154.
102. Schuelke M, Elsner A, Finckh B, Kohlschütter A, Hübner C & Brigelius-Flohé R (2000) Urinary α-tocopherol metabolites in α-tocopherol transfer protein-deficient patients. Journal of Lipid Research 41, 1543-1551.
103. Sen CK, Khanna S & Roy S (2004) Tocotrienol - the natural vitamin E to defend the nervous system? Vitamin E and Health 1031, 127-142.
104. Sen CK, Khanna S & Roy S (2006) Tocotrienols: vitamin E beyond tocopherols. Life Science 78, 2088-2098.
105. Sen CK, Khanna S, Roy S & Packer L (2000) Molecular basis of vitamin E action - tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. Journal of Biological Chemistry 275, 13049-13055.
106. Serbinova E, Kagan V, Han D & Packer L (1991) Free radical recycling and intramembrane mobility in the antioxidant properties of α-tocopherol and α-tocotrienol. Free Radical Biology and Medicine 10, 263-275.
107. Sontag TJ & Parker RS (2002) Cytochrome P450 ω-hydroxylase pathway of tocopherol catabolism: novel mechanism of regulation of vitamin E status. Journal of Biological Chemistry 277, 25290-25296.
108. Stahl W, Graf P, Brigelius-Flohé R, Wechter W & Sies H (1999) Quantification of the α- and γ-tocopherol metabolites 2,5,7,8-tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman and 2,7,8-trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman in human serum. Analytical Biochemistry 275, 254-259.
109. Stocker R & Keaney JF (2004) Role of oxidative modifications in atherosclerosis. Physiological Reviews 84, 1381-1478.
110. Stone WL & Papas A (2003) Tocopherols, tocotrienols and vitamin E. In Lipids for Functional Foods and Nutraceuticals, pp. 53-72 [FD Gunstone, editor]. Bridgewater: The Oily Press.
111. Stone WL, Papas AM, LeClair IO, Qui M & Ponder T (2002) The influence of dietary iron and tocopherols on oxidative stress and ras-p21 levels in the colon. Cancer Detection and Prevention 26, 78-84.
112. Swanson JE, Ben RN, Burton GW & Parker RS (1999) Urinary excretion of 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxychroman is a major route of elimination of γ-tocopherol in humans. Journal of Lipid Research 40, 665-671.
113. Sylvester PW, Nachnani A, Shah S & Briski KP (2002) Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pacific Journal of Clinical Nutrition 11, S452-S459.
114. Sylvester PW, Russell M, Ip MM & Ip C (1986) Comparative effects of different animal and vegetable fats fed before and during carcinogen administration on mammary tumorigenesis, sexual maturation, and endocrine function in rats. Cancer Research 46, 757-762.
115. Takahashi K & Loo G (2004) Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells. Biochemical Pharmacology 67, 315-324.
116. Tanabe M, Fukushima T, Usui N, Aoyama N, Tsunoda M & Imai K (2004) Intravenous administration of 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxy chroman (γ-CEHC) to rats and determination of its plasma concentration and urinary sodium excretion. Biomedical Chromatography 18, 727-734.
117. Tappel A & Zalkin H (1960) Inhibition of lipid peroxidation in microsomes by vitamin E. Nature 185, 35.
118. Tasinato A, Boscoboinik D, Bartoli GM, Maroni P & Azzi A (1995) D-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proceedings of the National Academy of Sciences USA 92, 12190-12194.
119. Theriault A, Chao JT & Gapor A (2002) Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis 160, 21-30.
120. Traber MG (2004) Vitamin E, nuclear receptors and xenobiotic metabolism. Archives of Biochemistry and Biophysics 423, 6-11.
121. Traber MG & Arai H (1999) Molecular mechanisms of vitamin E transport. Annual Review of Nutrition 19, 343-355.
122. Traber MG & Kayden HJ (1989) Preferential incorporation of α-tocopherol vs γ-tocopherol in human lipoproteins. American Journal of Clinical Nutrition 49, 517-526.
123. Traber MG, Siddens LK, Leonard SW, Schock B, Gohil K, Krueger SK, Cross CE & Williams DE (2005) α-Tocopherol modulates Cyp3a expression, increases γ-CEHC production, and limits tissue γ-tocopherol accumulation in mice fed high γ-tocopherol diets. Free Radical Biology and Medicine 38, 773-785.
124. Upston JM, Kritharides L & Stocker R (2003) The role of vitamin E in atherosclerosis. Progress in Lipid Research 42, 405-422.
125. Uto H, Kiyose C, Saito H, Ueda T, Nakamijra T, Igarashi O & Kondo K (2004) γ-Tocopherol enhances sodium excretion as a natriuretic hormone precursor. Journal of Nutritional Science and Vitaminology (Tokyo) 50, 277-282.
126. Vivekananthan DP, Penn MS, Sapp SK, Hsu A & Topol EJ (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361, 2017-2023.
127. Wagner KH, Kamal-Eldin A & Elmadfa I (2004) γ-Tocopherol - an underestimated vitamin? Annals of Nutrition and Metabolism 48, 169-188.
128. Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA & Redinbo MR (2001) The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292, 2329-2333.
129. Wechter JW, Kantoci D, Murray ED, D'Amico DC, Jung ME & Wang W-H (1996) A new endogenous natriuretic factor: LLU-α. Proceedings of the National Academy of Sciences USA 93, 6002-6007.
130. Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, Taylor PR, Virtamo J & Albanes D (2005) Serum α-tocopherol and γ-tocopherol in relation to prostate cancer risk in a prospective study. Journal of the National Cancer Institute 97, 396-399.
131. Weiser H & Vecchi M (1982) Stereoisomers of α-tocopheryl acetate. II. Biopotencies of all eight stereoisomers, individually or in mixtures, as determined by rat resorption-gestation tests. International Journal for Vitamin and Nutrition Research 52, 351-370.
132. Yamashita K, Iizuka Y, Imai T & Namiki M (1995) Sesame seed and its lignans produce marked enhancement of vitamin-E activity in rats fed a low α-tocopherol diet. Lipids 30, 1019-1028.
133. Yamashita K, Nohara Y, Katayama K & Namiki M (1992) Sesame seed lignans and γ-tocopherol act synergistically to produce vitamin-E activity in rats. Journal of Nutrition 122, 2440-2446.
134. Yap SP, Yuen KH & Wong JW (2001) Pharmacokinetics and bioavailability of α-, γ- and δ-tocotrienols under different food status. Journal of Pharmacy and Pharmacology 53, 67-71.
135. Zhou C, Tabb MM, Sadatrafiei A, Grün F & Blumberg B (2004) Tocotrienols activate the steroid and xenobiotic receptor, SXR, and selectively regulate expression of its target genes. Drug Metabolism and Disposition 32, 1075-1082.
136. Zingg JM & Azzi A (2004) Non-antioxidant activities of vitamin E. Current Medicinal Chemistry 11, 1113-1133.